Characterization of BRD4 during mammalian post-meiotic sperm development by Bryant, Jessica M. et al.
 1
Title: Characterization of BRD4 during mammalian post-meiotic sperm development  1 
 2 
Authors: Jessica M. Bryant1,2,3, Greg Donahue1, Xiaoshi Wang4, Mirella Meyer-Ficca5, Lacey 3 
J. Luense1, Angela H. Weller1, Marisa S. Bartolomei1, Gerd A. Blobel6, Ralph G. Meyer5, 4 
Benjamin A. Garcia4, and Shelley L. Berger1,# 5 
 6 
1Epigenetics Program, Department of Cell and Developmental Biology, University of 7 
Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA  8 
2Biomedical Graduate Studies, University of Pennsylvania  3Current address: Institut Pasteur, 9 
Paris, France 75724  4Epigenetics Program, Department of Biochemistry and Biophysics, 10 
University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, 11 
USA 5Department of Animal Biology, School of Veterinary Medicine, University of 12 
Pennsylvania, Pennsylvania 19104, current address: Department of Animal, Dairy and 13 
Veterinary Sciences, School of Veterinary Medicine, College of Agriculture and Applied 14 
Sciences, Utah State University, Logan, Utah, 84322, USA 6Division of Hematology, The 15 
Children's Hospital of Philadelphia, The Perelman School of Medicine at the University of 16 
Pennsylvania, Philadelphia, PA 19104, USA  #Correspondence should be addressed to S.L.B. 17 
(e-mail: bergers@mail.med.upenn.edu) 18 
 19 
Running title:  Characterization of BRD4 in mammalian spermiogenesis 20 
 21 
Materials and Methods word count:  2,011 22 
Introduction, Results, and Discussion word count: 4,969 23 
 24 
MCB Accepted Manuscript Posted Online 17 February 2015
Mol. Cell. Biol. doi:10.1128/MCB.01328-14
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
 2
ABSTRACT 25 
During spermiogenesis, the post-meiotic phase of mammalian spermatogenesis, transcription is 26 
progressively repressed as nuclei of haploid spermatids are compacted through a dramatic 27 
chromatin reorganization involving hyper-acetylation and replacement of most histones with 28 
protamines. Although BRDT functions in transcription and histone removal in spermatids, it is 29 
unknown whether other BET family proteins play a role.  Immunofluorescence of 30 
spermatogenic cells revealed BRD4 in a ring around the nuclei of spermatids containing hyper-31 
acetylated histones.  The ring lies directly adjacent to the acroplaxome, the cytoskeletal base of 32 
the acrosome, previously linked to chromatin reorganization.  The BRD4 ring does not form in 33 
acrosomal mutant mice.  ChIP sequencing in spermatids revealed enrichment of BRD4 and 34 
acetylated histones at the promoters of active genes.  BRD4 and BRDT show distinct and 35 
synergistic binding patterns, with a pronounced enrichment of BRD4 at spermatogenesis-36 
specific genes.  Direct association of BRD4 with acetylated H4 decreases in late spermatids as 37 
acetylated histones are removed from the condensing nucleus in a wave following the 38 
progressing acrosome.  These data provide evidence for a prominent transcriptional role of 39 
BRD4 and suggest a possible removal mechanism for chromatin components from the genome 40 
via the progressing acrosome as transcription is repressed in response to chromatin condensation 41 
during spermiogenesis.  42 







Mammalian spermatogenesis has emerged as a focus of epigenetic study, as this 49 
conserved process requires vast changes in transcription and chromatin organization (1).  50 
Spermatogenesis, or the formation of the mature male gamete, takes place in the seminiferous 51 
tubules of the testes and begins with the stem-like spermatogonia.  Diploid spermatogonia can 52 
differentiate into spermatocytes, which enter meiosis to produce four genetically unique haploid 53 
round spermatids (Fig. 1A).  During the post-meiotic process of spermiogenesis, a spermatid 54 
differentiates into a motile spermatozoon by shedding most cytoplasm, forming a flagellum, and 55 
compacting the nucleus.   56 
In mice, nuclear morphology changes dramatically during spermiogenesis: the nucleus is 57 
initially round (in round spermatids), then elongates (in elongating spermatids), and finally 58 
condenses into a small hook-like shape (in condensing/condensed spermatids) (Fig. 1A).  This 59 
process is necessary for the formation of fertile sperm and involves chromatin compaction and 60 
consequent vast transcriptional repression (1).  Nuclear compaction is accomplished via near-61 
complete replacement of canonical histones, some with testes-specific histone variants; but most 62 
histones are initially replaced with transition proteins and then with protamines (2).  Although 63 
several groups have shown that the small percentage of histones that remain associated with the 64 
genome in mature sperm are specifically post-translationally modified and enriched at 65 
developmentally important loci (3, 4) and gene regulatory sequences (5), recent studies have 66 
provided contrasting evidence that in mouse sperm, histone retention occurs preferentially in 67 
large gene-poor genomic regions (6-8).  The mechanism by which almost all histones are 68 
removed and degraded has yet to be elucidated, but several important factors in this process 69 
have been discovered (9).   70 
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Chromatin reorganization during spermiogenesis begins concurrently with acrosome 71 
formation and histone hyper-acetylation.  The acrosome is a cap-like, membrane-bound 72 
organelle derived from the Golgi apparatus that covers the apical part of the mature sperm 73 
nucleus.  This organelle contains digestive enzymes that are released upon contact with the egg 74 
to facilitate fertilization.  Acrosome biogenesis begins after meiosis is complete and is 75 
accomplished via fusion of fragments of the Golgi apparatus at the acroplaxome, or the 76 
cytoskeletal base of the forming acrosome (10).  The acroplaxome consists of actin and keratin 77 
and anchors the acrosome to the adjacent nuclear membrane of the spermatid.  Recently, several 78 
studies have linked acrosome biogenesis to the dramatic chromatin reorganization that takes 79 
place during spermiogenesis.  Mouse mutants with defective acrosome formation produce 80 
abnormal, round-headed sperm that show defective nuclear compaction (11-15).  Moreover, 81 
histone removal in human spermatids takes place adjacent to the acroplaxome as the acrosome 82 
progressively caps the nucleus (16).  These studies suggest that acrosome biogenesis plays a role 83 
in sperm head shaping and nuclear compaction, but the mechanisms by which this may happen 84 
are unknown.    85 
After meiosis is complete and acrosome formation has begun, histones become hyper-86 
acetylated in the spermatid nucleus (17-19).  Histone hyper-acetylation is believed to facilitate 87 
histone removal either through a direct loosening of the chromatin or via binding of 88 
bromodomain-containing proteins such as PA200, the activator of the “spermatoproteasome”, 89 
and BRDT, the testes-specific BET (Bromo- and Extra-Terminal domain) family protein (20-90 
23).  Like all BET family members, BRDT contains two bromodomains at its N-terminus and an 91 
extra-terminal (ET) domain at its C-terminus.  Recently, BRDT has been shown to play a dual 92 
role during spermatogenesis (24).  First, BRDT plays a transcriptional role, binding to 93 
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acetylated histones and P-TEFb at the promoters of meiotic and post-meiotic genes that are 94 
aberrantly repressed in its absence (25).  In fact, Brdt knockout or treatment of male mice with 95 
JQ1 – a small-molecule inhibitor of BET family proteins – results in meiotic arrest and a 96 
significant decrease in fertility (25, 26).  Second, BRDT may play a structural role in chromatin 97 
dynamics during spermiogenesis.  Mice expressing BRDT lacking the first bromodomain show 98 
defects in fertility caused by abnormal nuclear compaction and chromatin organization during 99 
spermiogenesis (20, 27).  However, it is unclear whether these later defects are again due to 100 
transcriptional de-regulation or rather to decreased binding of BRDT to hyper-acetylated 101 
histones. 102 
It is also unclear whether other members of the BET family are integral to the process of 103 
spermatogenesis, as Brd2 and Brd4 null mouse mutants show embryonic lethality (28, 29).  104 
However, these genes are expressed during spermatogenesis at the mRNA and protein level 105 
(30).   Interestingly, Brd4 heterozygous null mice show defects in spermatogenesis, although 106 
this phenotype has not been well characterized (29).  BRD4 has been shown to bind to the 107 
acetylated tails of histones H3 and H4 and is generally associated with active gene transcription 108 
(31).  However, BRD4 also plays non-transcriptional roles such as tethering the human 109 
papilloma virus genome to host chromatin during mitosis (32).   110 
In this study, we investigate BRD4 during spermiogenesis.  We show that BRD4 is 111 
found in post-meiotic cells and investigate a novel BRD4 ring structure in spermatid nuclei that 112 
is closely associated with the acrosome.  Moreover, we show with ChIP sequencing that BRD4 113 
has an unanticipated prominent association with genes expressed in post-meiotic cells. Taken 114 
together, our results suggest an interesting mechanism for nuclear protein removal by linking 115 
BRD4 and transcription shutdown to acrosome formation during spermiogenesis. 116 
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RESULTS 117 
BRD4 is expressed in meiotic cells and spermatids, but not in mature sperm 118 
Although a transcriptional role of BRDT has been demonstrated during meiosis and 119 
spermiogenesis, it is unclear if other BET family proteins play a role in spermatogenesis (25).  120 
As mentioned above, Brd4 heterozygous null male mice show spermatogenic defects, 121 
suggesting that BRD4 may play a role in spermatogenesis (28, 29).  To investigate the 122 
expression pattern of BRD4 over the course of spermatogenesis, we analyzed protein levels in 123 
different cell types obtained by STA-PUT velocity sedimentation from mature mouse testes 124 
(33).  With this method, we collected four cell populations (see Fig. 1A): 1) a mixture of meiotic 125 
cells (spermatocytes: Sc), 2) early post-meiotic spermatids (round spermatids: RSp), 3) later 126 
post-meiotic spermatids (elongating and condensing spermatids: E/CSp), and 4) a mixture of 127 
early and later spermatids (R/E/CSp).  Mature sperm were isolated from the cauda epididymis of 128 
wild-type mice.   129 
In addition to microscopic verification of purity via cellular and nuclear morphology 130 
[see (33) for our methods], we used western blot analysis of lysates from these cells to confirm 131 
relative purity.  Although H4 protein is depleted in late spermatids (E/CSp), H4K5,8,12,16ac, 132 
but not H3K9ac, was relatively enriched in these elongating and condensing spermatids (Fig. 133 
1B).  This analysis also revealed the presence of the long isoform of BRD4 protein (indicated 134 
with an asterisk Fig. 1B) in meiotic cells (“Sc”), round spermatids (“RSp”), and 135 
elongating/condensing spermatids (“E/CSp”), but not in mature sperm (“Sperm”).  A second 136 
smaller BRD4 isoform or degradation product was also detected in later spermatids (arrow in 137 
Fig. 1B, upper panel).  The specificity of the BRD4 antibody for the long and shorter forms was 138 
confirmed by peptide competition (second panel, Fig. 1B).  The canonical BRD4 short isoform 139 
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(~723aa) was not detected in any spermatogenic cells in this analysis.  In addition to BRD4, 140 
BRDT and BRD2 are expressed over the course of spermatogenesis.  While BRDT is expressed 141 
most highly in spermatocytes, BRD2 and BRD4 protein levels increase over the course of 142 
spermiogenesis.        143 
 144 
BRD4 forms a ring around the nucleus of spermatids as histones become hyper-acetylated  145 
To gain insight into a possible function for BRD4 during spermatogenesis, we 146 
determined its subcellular localization by performing indirect immunofluorescence (IF) on 147 
tissue sections from the testes of adult wild-type male mice.  Using intact tissue allows for the 148 
identification of specific steps of spermatogenesis within the seminiferous tubules (34).  149 
Interestingly, we detected BRD4 in a distinct, complete ring around the nucleus beginning in 150 
approximately stage 7-8 spermatids (Sp) (Fig. 2A).  The BRD4 ring is not present in 151 
spermatogonia or spermatocytes (Sc) (Fig. 2A) and appears concurrently with the post-meiotic 152 
hyper-acetylation of histones in the nucleus, not seen in spermatocytes (compare Sp to Sc in Fig. 153 
2B).  We confirmed that the apparently distinct “ring” is not associated with the entire nuclear 154 
periphery with pseudo-3D images created with z-stacked individual confocal images of early 155 
and late elongating spermatid nuclei (Movies A and B, resp.).  We found the BRD4 structure 156 
closely changes shape along with the condensing nucleus of the spermatid: from round to 157 
oblong, always at the periphery of the DAPI-stained nucleus (Fig. 2A,B and Movies A,B).  This 158 
ring structure is specific to BRD4, as IF analysis of a mixed population of spermatogenic cells 159 
showed BRD2 and BRDT in a diffuse nuclear staining pattern in spermatocytes and round 160 
spermatids (Fig. 2C,D).  161 
 162 
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BRD4 forms a ring within the nuclear envelope at the base of the acrosome  163 
To further investigate the sub-cellular location of BRD4, we performed indirect IF for 164 
BRD4 and Lamin B1, a key component of the nuclear membrane.  Co-detection of these 165 
proteins revealed that BRD4 is located at an important transitional region of the nuclear 166 
membrane in spermatids (Fig. 3A).  More specifically, Lamin B1 and nuclear pores become 167 
polarized to the posterior end of the spermatid nuclear membrane, clearly distinct from the 168 
anterior end, which becomes closely covered by the acrosome (Fig. 3B, acrosome location 169 
indicated by an asterisk in Fig. 3A) (35-37).  The acrosome is partly anchored to the nuclear 170 
envelope by a cytoskeletal plate called the acroplaxome, which forms a ring-like structure very 171 
similar to the BRD4 ring in the region where the Lamin B1-associated nuclear envelope meets 172 
the acrosome-associated nuclear envelope (Fig. 7D) (10).  Therefore, we hypothesized that 173 
BRD4 may be associated with the acroplaxome.      174 
To determine whether the BRD4 ring is linked to the acrosome/acroplaxome, we 175 
performed IF on spermatogenic cells, probing with fluorophore-conjugated peanut agglutinin 176 
(PNA) to detect the acrosome, or with phalloidin to detect actin in the acroplaxome (Fig. 3C and 177 
Movie C, respectively).  Indeed, the BRD4 ring appears directly at the base of the acrosome 178 
during capping in late round spermatids (top panel) and persists in elongating (middle panel) 179 
and condensing spermatids (bottom panel) (Fig. 3C). Using a confocal microscope to create a 180 
pseudo-3D image, we discovered that the BRD4 ring lies just adjacent to the actin ring of the 181 
acroplaxome, but closer to the DAPI-stained nucleus (Movie C).   182 
To provide additional evidence of the acrosome-associated BRD4 ring, we incubated 183 
spermatogenic cells with JQ1-biotin followed by fluorophore-conjugated streptavidin.  JQ1 is a 184 
small molecule that binds to the bromodomains of all BET family proteins, which are expressed 185 
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in the nucleus of multiple spermatogenic cell types [Fig. 2C,D and (30, 38, 39)].  Thus, JQ1-186 
biotin shows a diffuse nuclear staining pattern in most spermatogenic cells types (Fig. 3D, top 187 
panel); however, this staining is not a random artifact of streptavidin binding (Fig. 3D, bottom 188 
panel).  Importantly, in addition to a diffuse nuclear staining, JQ1-biotin is enriched in a ring 189 
structure that overlaps with the BRD4 ring in spermatids [late round (top panel) and elongating 190 
(bottom panel) spermatids in Fig. 3E].  Moreover, this JQ1-biotin enrichment is found at the 191 
base of the acrosome, providing additional evidence for the existence of the BRD4 ring (Fig. 192 
3F). 193 
Because the BRD4 ring and the acroplaxome are remarkably similar in shape and 194 
location, we hypothesized that acrosome formation is needed for BRD4 ring formation.  To test 195 
this hypothesis, we analyzed Hrb (also known as Agfg1) null mice, which produce infertile 196 
sperm that lack acrosomes and have round, poorly compacted nuclei (11).  In wild-type male 197 
mice, the acrosome is formed by the fusion at the acroplaxome of proacrosomic vesicles derived 198 
from the Golgi apparatus (Fig. 4A, top panels) (40).  In Hrb-/- male mice, the proacrosomic 199 
vesicles begin to form in round spermatids, but they are unable to fuse properly to form a 200 
mature acrosome (Fig. 4A, bottom panels).  Hrb-/- mice also show defects in nuclear elongation 201 
and compaction later in condensing spermatids when the acrosome is completely absent (Fig. 202 
4A, bottom right panel).   203 
To determine if acrosome development is required for BRD4 ring formation, we 204 
performed indirect IF on cryosectioned testes tissue from adult Hrb+/- (which have normal 205 
spermatogenesis) and Hrb-/- mice (11).  Strikingly, the BRD4 ring does not form properly in 206 
Hrb-/- mice (Fig. 4B, right panel).  A small amount of BRD4 can be seen around spermatid 207 
nuclei in Hrb-/- mice, but the conspicuous ring structure never develops and exists only in small 208 
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fragments, if at all, in late stage spermatids (Fig. 4B, right panel).  Because the acroplaxome 209 
forms partially, although aberrantly, in Hrb-/- acrosomal mutant mice, it is possible that the 210 
BRD4 ring is able to form partially due to an association with certain components of the 211 
acroplaxome that may be able to assemble in Hrb-/- mice despite the lack of a functional 212 
acrosome (41). 213 
 214 
BRD4 is enriched at the promoters of active genes in spermatids 215 
It is possible that BRD4 is present diffusely throughout the nucleus in round spermatids, 216 
undetectable by IF until it is present in a higher concentration in the ring structure in very late 217 
round spermatids.  To determine if BRD4 interacts with the genome in spermatids, we analyzed 218 
the genome-wide enrichment of BRD4 with chromatin immunoprecipitation followed by 219 
sequencing (ChIP-seq).  We performed analysis in round spermatids to characterize BRD4 220 
binding in the context of the distinct post-meiotic gene expression program, as a previous study 221 
has done for BRDT (25).  We also determined the genome-wide localization of various other 222 
histone post-translational modifications (PTMs) to assess whether BRD4 shows a binding 223 
preference for any of these PTMs (all of which were normalized to input).  All ChIP-seq data 224 
alignment information can be found in Table 1.     225 
Upon initial examination of the ChIP-seq data, it is evident that BRD4 and H3 and H4 226 
acetylation (H3/H4ac) are enriched in genic regions of the genome as opposed to an established 227 
heterochromatin PTM, H3K9me3, which is enriched in large intergenic regions (Fig. 5A).  228 
Indeed, bioinformatic analysis revealed that the majority of peaks of BRD4, H3ac, and H4ac are 229 
located within promoters [1 kilobasepair (kb) upstream of the transcriptional start site (TSS)] or 230 
genes (introns or exons), unlike H3K9me3, which is located primarily in intergenic regions (Fig. 231 
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5B).  Upon closer examination, BRD4 is enriched at the TSS of active housekeeping genes such 232 
as Actb and active spermatogenesis-specific genes such as Tnp1 (Fig. 5C).  Conversely, BRD4 233 
is not found at repressed housekeeping genes such as Myc  (Fig. 5C). BRD4 is not bound to all 234 
active genes even though some, such as Vps45, may be enriched for H3 or H4 acetylation (Fig. 235 
5C).   236 
In addition, we did not observe significant differences in enrichment patterns among 237 
acetylation at different H3 and H4 residues.  In general, H3K9ac and H4K5, 8, 12, and 16ac 238 
appear to be enriched surprisingly similarly at the TSS of active genes (Fig. 5A,C).  Although 239 
BRD4 is not present at the TSS of all active genes, heat map analysis revealed that levels of 240 
BRD4, H3K9ac, and H4ac at gene promoters (green in Fig. 6A) show a strong correlation with 241 
levels of transcriptional activity of those genes in round spermatids [red in Fig. 6A, transcription 242 
data from (42, 43)].    243 
We compared our BRD4 ChIP-seq data in round spermatids to previously published 244 
BRDT ChIP-seq data from the same cell type (25).  Although this previous study showed that 245 
BRDT binds to the TSS of active genes in round spermatids, we found the majority of BRDT 246 
peaks (~64%) to be present in intergenic regions of the genome and only 3% of peaks within 247 
gene promoters (Fig. 5B).  However, BRDT enrichment at gene promoters does correlate with 248 
the transcriptional activity of those genes (Fig. 6A).  These data suggest that while most BRDT 249 
is found in intergenic regions, the small percentage located at gene promoters correlates well 250 
with transcriptional activity. 251 
Because both BRD4 and BRDT were found to bind to the promoters of active genes in 252 
round spermatids, we sought to investigate possible differences between the roles of these BET 253 
family proteins.  We defined a list of genes bound by BRD4 based on the presence of peaks 1kb 254 
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upstream of the TSS.  We then intersected this list with a list of approximately 1,544 genes 255 
previously shown to be bound by BRDT in round spermatids (25).  Thus, we generated three 256 
categories of genes: BRD4-bound (approximately 2,093 genes), BRDT-bound (approximately 257 
1,347 genes), and co-bound (approximately 197 genes).  Genes bound only by BRD4 showed an 258 
average expression level that is slightly higher than genes bound only by BRDT (Fig. 6B).  259 
However, the average expression levels of BRD4- or BRDT-bound genes were approximately 260 
two-fold higher than the average expression level of all genes and similar to the average 261 
expression level of spermatogenesis-specific genes [p < 2.2e-16 for BRD4- and BRDT-bound in 262 
(Fig. 6B)].  Interestingly, genes that were co-bound by BRD4 and BRDT show the highest 263 
average transcription level [p < 2.2e-16 in (Fig. 6B)].  These same trends can be seen with levels 264 
of H3 and H4 acetylation at genes bound by BRD4, BRDT, or both (Fig. 6C).  Histone H3/H4 265 
acetylation levels are higher at the promoters of genes that are only bound by BRD4, but are 266 
highest at the promoters of genes that are co-bound by BRD4 and BRDT [see Table 2 for p-267 
values in (Fig. 6B,C)].  As a control, H3K9me3 enrichment is extremely low at the promoters of 268 
genes bound by BRD4 and BRDT.     269 
Next, we performed Gene Ontology (GO) analysis of BRD4-, BRDT-, or co-bound 270 
genes to determine if BRD4 and BRDT could possibly regulate different categories of genes.  271 
Categories of housekeeping genes such as “RNA processing” or “protein folding” can be found 272 
in genes bound by BRD4 or BRDT only (Fig. 6D,E left two panels).  However, 273 
spermatogenesis-specific genes are enriched in the gene set bound by BRD4 only or co-bound 274 
by BRD4 and BRDT (Fig. 6D,E left and right panels).  Indeed, heatmap analysis of BRD4 and 275 
BRDT enrichment at the TSS of all spermatogenesis-specific genes reveals a strong positioning 276 
of BRD4 (Fig. 6F).  These data suggest that BRD4 and BRDT both play a role in the activation 277 
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of transcription in post-meiotic spermatids, but that BRD4 may play a particularly strong role in 278 
activation of spermatogenesis-specific genes.  279 
The necessity of BRD4 in transcriptional activation during spermiogenesis is difficult to 280 
determine in the current absence of a conditional knockout mouse or reliable spermatogenic cell 281 
culture system.  Knockdowns in the germline are extremely difficult to generate, and staged cell 282 
populations are not easily obtainable or manipulated in cell culture.  Moreover, treatment of 283 
male mice with JQ1 results in a meiotic arrest, before spermiogenesis (26).  Thus, currently we 284 
are unable to directly test the function of BRD4 during spermiogenesis. 285 
  286 
BRD4 association with poly-acetylated histone H4 diminishes in late spermatids as 287 
acetylated histones are removed from the condensing nucleus 288 
Although our ChIP-sequencing data provides correlative evidence of BRD4 binding to 289 
both acetylated histone H3 and H4, it does not demonstrate direct binding to these histone 290 
PTMs.  To investigate the composition of BRD4-associated chromatin, we performed 291 
immunoprecipitation (IP) of BRD4 in round spermatids (Fig. 7A).  Total cell lysate and BRD4-292 
immunoprecipitated proteins were separated on an SDS-PAGE gel and analyzed with mass 293 
spectrometry.  We quantified the fraction of peptides bearing different combinations of acetyl 294 
and methyl PTMs for histones H3 and H4 in total chromatin and BRD4-immunoprecipitated 295 
chromatin (Table 3).  When the values of immunoprecipitated peptides were normalized to the 296 
values for total chromatin in round spermatids, we noticed an approximate 4- and 10-fold 297 
enrichment of tri- and tetra-acetylated H4 peptide, respectively (log-transformed ratios in Fig. 298 
7A bottom left panel; see Table 3 for raw values).  Specifically, various combinations of tri- and 299 
tetra-acetylated H4 peptides (K5, 8, 12, and 16ac) were highly enriched in immunoprecipitated 300 
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chromatin, but all these most highly enriched combinations include H4K5ac or H4K8ac (Fig. 301 
7A right panel and Table 3).  In general, H3K9ac is not enriched in BRD4-immunoprecipitated 302 
chromatin and H3K14ac is only slightly enriched when combined with different degrees of 303 
H3K9 methylation (Fig. 7A upper left panel).  The reason for the relative absence of H3 304 
acetylation and higher H3K9me3 is not clear.   305 
 We then quantified the change in total and BRD4-immunoprecipitated H4 acetylation 306 
over the course of spermatogenesis (raw values in Table 4).  We generated ratios of H4 307 
acetylation in round spermatids versus spermatocytes and compared these to the ratio of H4 308 
acetylation in elongating/condensing spermatids versus round spermatids.  First, tri- and tetra-309 
acetylated H4 peptide levels increase significantly in total chromatin over the course of 310 
spermiogenesis (from spermatocytes to round spermatids to elongating/condensing spermatids) 311 
(Fig. 7B left graph).  Although levels of BRD4-immunopreceipitated mono-, tri-, and tetra-312 
acetylated H4 increase from spermatocytes to round spermatids, the levels of tetra-acetylated H4 313 
decrease significantly from round spermatids to elongating/condensing spermatids (Fig. 7B right 314 
graph).  Interestingly, the immunofluorescent signal of hyper-acetylated histones is depleted 315 
from the nuclear region underlying the acrosome (Movie D), as was shown in human spermatids 316 
(16), and adjacent to the BRD4 ring (Fig.  7C).  Taken together, these data suggest a localization 317 
of BRD4 from the genome to the ring structure followed by removal of hyper-acetylated 318 
histones from the genome as the acrosome caps the nucleus (see model in Fig. 7D).  319 
 320 
DISCUSSION          321 
Mammalian spermatogenesis results in a specialized sperm cell with a highly compacted 322 
nucleus.  A hallmark of this nuclear compaction is the removal of almost all histones from the 323 
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genome, with a small percentage retained at developmentally important loci (3, 4) and repetitive 324 
DNA sequences (7, 8).  While the mechanism of mass histone removal and degradation remains 325 
unclear, it is believed that histone hyper-acetylation and thus, bromodomain-containing proteins, 326 
especially BRDT, are integral to this process (2, 20, 21, 25, 27).  Surprisingly little is known 327 
about the involvement of the other BET family members – BRD2, BRD3, and BRD4 – during 328 
spermiogenesis.  A previous study used immunohistochemistry of testes tissue to show BRD4 329 
expression specifically in spermatogonia (30).  In this study, however, we found that BRD4 is 330 
expressed during meiotic and post-meiotic phases of mouse spermatogenesis using several 331 
approaches.  First, we detect BRD4 gene expression in meiotic and post-meiotic cells with 332 
western blotting and RT-qPCR (Fig. 1B and data not shown).  Second, we immunoprecipitated 333 
BRD4 from meiotic and post-meiotic cells and detect its association with expressed genes and 334 
with acetylated histones [(44) and Figs. 5, 6, and 7].  Thus, BRD4 protein is present during the 335 
post-meiotic phase of spermatogenesis.   336 
Our characterization of BRD4 in spermatids provides evidence for an interesting 337 
mechanism by which transcription is attenuated by the progressive removal of BRD4 itself and 338 
acetylated histones via the acrosome.  It is possible that this might be a general mechanism for 339 
removal of transcriptionally relevant proteins.  We initially observed BRD4 in a novel ring-like 340 
structure that is closely associated, both spatially and functionally, with the 341 
acrosome/acroplaxome.  However, our unprecedented combination of IP/mass spectrometry and 342 
ChIP-seq analysis of BRD4 with endogenous antibodies demonstrate the in vivo binding of 343 
BRD4 throughout the chromatin of post-meiotic cells.  Importantly, we performed these 344 
analyses in round spermatids, just before the BRD4 ring first appears and an increase in histone 345 
H4 acetylation can be detected by western blot, IF, and mass spectrometry (Figs. 1B, 2A,B and 346 
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7B).  Also, in this cell type, we were able to capture the chromatin state before the initiation of 347 
histone replacement, vast compaction, and transcriptional shutdown.  348 
BRD4 has traditionally been associated with euchromatin, active transcription, or mitotic 349 
bookmarking (45-51).  Our ChIP-sequencing data suggest that BRD4 plays a similar role in 350 
transcriptional activation in round spermatids.  BRD4, H3K9ac, and H4K5,8,12, and 16ac are 351 
present at the TSS of active genes in round spermatids, and their enrichment correlates with 352 
transcription levels (Figs. 5 and 6A).  While BRD4 is known to bind to poly-acetylated histone 353 
H4 in vitro, our study is the first to confirm this preference for acetylated H4 (especially poly-354 
acetylated H4 modified at K5 and K8) over H3 by in vivo IP/mass spectrometry using an 355 
antibody against endogenous BRD4 [Fig. 7A and (49, 52, 53)].  356 
When we compared our ChIP-sequencing data to that published in a recent study of 357 
BRDT in the same cell type (25), we found that BRD4 and BRDT enrichment at gene promoters 358 
correlates with the transcriptional activity of those genes (Fig. 6A).  BRD4 is especially 359 
enriched at spermatogenesis-specific genes and shows a very robust positioning around their 360 
TSS, suggesting that this BET family protein may play a strong role in their activation (Fig. 6F).  361 
Interestingly, genes that were co-bound by BRD4 and BRDT showed higher average 362 
transcription and histone acetylation levels than genes bound only by BRD4 or BRDT (Fig. 363 
6B,C).  It is unclear how BRD4, BRDT, or both would be recruited to specific subsets of genes, 364 
but these data suggest that synergistic binding of these two BET family proteins could lead to 365 
higher histone acetylation and expression levels via increased recruitment of the P-TEFb 366 
complex, as has been shown for both BRD4 and BRDT (25, 50, 51).  367 
Although BRDT binds to a considerable number of gene promoters, we found that the 368 
majority of BRDT peaks occur in intergenic regions of the genome (Fig. 5B).  Interestingly, a 369 
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recent study demonstrated that nucleosomes that are retained in the mature mouse sperm 370 
genome show a ten-fold overrepresentation at promoter regions (54).  Because BRDT has also 371 
been implicated in the histone-to-protamine transition via removal of acetylated histones, we 372 
propose that BRDT may show a binding preference for regions where histones are largely 373 
evicted from the mature sperm genome, perhaps even as early as the round spermatid stage (20, 374 
23, 25). In the future, it will be interesting to investigate the genome-wide binding patterns of 375 
other BET family proteins over the course of spermatogenesis. 376 
Because transcription is largely de-activated as the genome is highly compacted during 377 
spermiogenesis, it is reasonable to postulate that BRD4 and other transcriptional co-activators 378 
must be removed from the genome during this process.  Indeed, western blot analysis shows that 379 
BRDT, BRD2, and BRD4 are largely absent from mature sperm (Fig. 1B).  It is currently 380 
unclear, however, how histones and so many other chromatin components may be removed 381 
and/or degraded during this nuclear condensation.  In approximately stage 7-8 spermatids, when 382 
histone hyperacetylation and nuclear elongating/compaction begin, the BRD4 ring appears just 383 
adjacent to the acroplaxome (Figs. 1B, 2B, 3C and Movies A-C).  At the same stage of 384 
spermiogenesis, we observed by western blot a BRD4 peptide of a slightly lower molecular 385 
weight than the full length BRD4 isoform (Fig. 1B).  It is possible that the BRD4 ring may 386 
contain a spermatid-specific isoform that binds to acetylated histones or other acetylated 387 
chromatin-associated proteins in order to provide a tethering force (via the acroplaxome) for 388 
chromatin compaction and reorganization.  Indeed, a growing body of evidence implicates 389 
BRD4 in structural roles such as tethering, insulating, and maintaining higher order chromatin 390 
structure (55-58).  Alternatively, because BRD4 is undetectable in mature sperm by IF and 391 
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western blot, this smaller BRD4 peptide may simply be a degradation product that is created 392 
during the removal of BRD4 from the genome via the acroplaxome-associated ring.  393 
Interestingly, the BRD4 ring does not form in acrosomal mutant mice, which show 394 
nuclear compaction and fertility defects that are highly similar to human globozoospermia, a 395 
condition in which the acrosome is malformed or absent, the sperm head is round, and 396 
chromatin compaction is abnormal [Fig. 4 and (11-15)].  Chromatin compaction during 397 
spermiogenesis may be incomplete in these mutant mice due to abnormal retention of 398 
chromatin-associated proteins and histones.  Future ChIP-sequencing studies in acrosomal 399 
mutant mice will elucidate potential defects in the chromatin signature characteristic of 400 
spermiogenesis.  401 
Our observations strongly support an increasing body of evidence that acrosome 402 
formation plays a key role in nuclear compaction and chromatin remodeling during 403 
spermiogenesis.  Our IF data in mouse (Fig. 7C and Movie D) and that of a recent study in 404 
human spermatids shows that acetylated histones in the nucleus are depleted first in the region 405 
directly adjacent to the acrosome, where initial DNA compaction occurs (16).  Moreover, 406 
various chromatin-associated proteins known to be involved in chromatin compaction, such as 407 
H1T2, are found in the nucleus adjacent to the acrosome (59). Finally, it has been suggested that 408 
the acroplaxome is able to provide contractile force to the compacting nucleus (10).  It is unclear 409 
whether histones are degraded within the nucleus or shuttled out of the nucleus first during 410 
spermiogenesis; however, recent studies have shown that histone removal, while delayed, still 411 
occurs in mice lacking PA200, the acetylated histone-binding activator of the spermatogenesis-412 
specific proteasome (21).   413 
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As histone removal followed by degradation appears to be the most supported model, the 414 
acroplaxome is in an ideal location to facilitate this potential shuttling (22).  It has been shown 415 
that the nuclear membrane underlying the expanding acrosomal cap is devoid of any nuclear 416 
pores and may be impenetrable to exiting nuclear components (37).  If the acrosome is coupled 417 
to the extensive removal of histones and other chromatin components from the genome, the 418 
force-providing acroplaxome could act to facilitate shuttling at the base of the acrosome where 419 
nuclear pores and lamins B1 and B3 are still present. Future studies, such as mass spectrometry 420 
analysis, will provide critical insight into potential binding partners or post-translational 421 
modifications of BRD4 that may localize this protein to the acroplaxome in spermatids.  422 
Regardless, this striking BRD4 localization suggests an interesting link between a chromatin 423 
component known to bind to acetylated histones and extra-nuclear spermatogenic structures.   424 
Our combined approaches of immunofluorescence, biochemistry, mass spectrometry, 425 
and ChIP-sequencing suggest that BRD4 may play a fundamental role in transcription of 426 
spermatogenesis-specific genes and then in the transition from the transcriptionally active 427 
genome of early post-meiotic spermatids to the highly compact, transcriptionally silent genome 428 
of mature sperm.  Importantly, our characterization of BRD4 contributes to the growing body of 429 
evidence that dramatic chromatin events taking place in the nucleus during spermiogenesis may 430 
be directly affected by extra-nuclear changes in cell structure and composition.  Further 431 
investigation should reveal other proteins that are also involved in this process and elucidate the 432 
mechanism by which histones and other chromatin components are removed from the genome 433 
in an apparently acrosome-dependent manner.  Finally, it would be interesting to further 434 
investigate how BET family proteins function during spermiogenesis to first activate 435 
transcription and then to repress it by potentially removing acetylated histones from the 436 
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spermatid genome. The future study of various steps in this intricate process of transcriptional 437 
repression and nuclear compaction will lead to a better understanding of chromatin dynamics 438 
during spermatogenesis, epigenetic signatures in sperm, and mammalian fertility. 439 
 440 
MATERIALS AND METHODS 441 
Antibodies/Reagents 442 
Application Antibodies/Reagents 
Immunofluorescence BRD2 (Abcam ab111078), BRD4 (60), BRDT (Abcam ab5157), 
H3K9Ac (Active Motif AM39137), H4K5,8,12,16ac (Millipore 05-
1355), JQ1-PEG2-biotin (39), Lamin B1 (Abcam ab16048), 
Lamin B1 (Santa Cruz sc-373918), phalloidin-488 (Invitrogen 
A12379), and PNA-488 (Invitrogen L21409) 
Western blot β-actin (Cell Signalling 4970), BRD2 (Lifespan Biosciences 
(aa524-573) IHC-plus LS-B923), BRD4 (60), BRDT (Abcam 
ab5157), Cyclin T1 (Santa Cruz H245 sc-10750), GAPDH 
(Fitzgerald 10R-G109a), H3K9Ac (Active Motif AM39137), H4 
(Abcam ab10158), H4K5ac (Millipore 07-327), H4K8Ac 
(Millipore 07-328), H4K12Ac (Millipore 07-595), H4K16Ac 
(Active Motif AM39167), H4K5,8,12,16ac (Millipore 05-1355) 
Immunoprecipitation/
ChIP 
H3 (Abcam ab1791), H3K9ac (Active Motif AM39137), H3K9me3 
(Abcam ab8898), H4K5ac (Millipore 07-327), H4K8ac (Millipore 
07-328), H4K12ac (Millipore 07-595), H4K16ac (Active Motif 




Mouse Models 445 
Male 129S6/SvEvTac mice (Taconics, Germantown, NY) as well as Hrb-/- gene-disrupted mice 446 
(11) were maintained and humanely euthanized according to the guidelines of the University of 447 
Pennsylvania Institutional Animal Care and Use Committee.  448 
 449 
Mouse spermatogenic cell fractionation 450 
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Spermatogenic cell fractionation was performed by sedimentation of cells prepared from adult 451 
mouse testes through a BSA gradient as previously described (33).  Each fractionation 452 
experiment used approximately 22 testes.  Fractions were analyzed for purity based on cell and 453 
nuclear morphology (via DAPI staining) and pooled.  Mature spermatozoa were obtained from 454 
epididymides of adult mice, and contaminating cell types were eliminated by incubating in 455 
somatic cell lysis buffer (0.1% SDS, 0.5% Triton X-100 in DEPC H2O) on ice for 20 minutes. 456 
 457 
Western blot analysis 458 
Cells were resuspended in buffer [20mM TrispH 7.5, 1mM MgCl2 , 1mM CaCl2, 137mM NaCl, 459 
10%Glycerol, 1% NP-40, Complete protease inhibitor EDTA-free (Roche), 300nM trichostatin 460 
A (Sigma T1952)], and rotated at 4°C for one hour in the presence of 12.5 U/mL Benzonase 461 
(Novagen 70746).  Protein content was measured with Bradford dye and cell lysate containing 462 
25μg of protein or sperm lysate containing 5μg of protein was added to each well of a 4-12% 463 
1mm Bis-Tris NuPAGE protein gel.  Protein was transferred to a PVDF membrane and blocked 464 
for one hour in 5% BSA-TBST.  Membranes were incubated with primary antibody (in 1% 465 
BSA-TBST) for one hour, washed, incubated with secondary HRP-conjugated antibody (in 1% 466 
BSA-TBST) for 30 minutes, washed, and detected using enhanced chemiluminescence.  For 467 
peptide competition, primary antibody was incubated with 5μg/mL immunizing peptide for one 468 
hour at room temperature before application to the membrane. 469 
 470 
Immunofluorescence 471 
Immunofluorescence was performed on 8μm cryosections of mouse testes from ten-week-old 472 
mice or cell suspensions obtained using the spermatogenic cell separation method described 473 
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above (33).  Testes were dissected and immediately placed in 4% PFA (in PBS) or snap frozen 474 
in liquid nitrogen.  The PFA-fixed testes were incubated in 15%, then 30% sucrose (in PBS) and 475 
embedded in TissueTek OCT compound.  Fixed or frozen tissue was cryosectioned onto 476 
Superfrost Plus slides (Fisher).  Cell suspensions in PBS were allowed to adhere to Superfrost 477 
Plus slides for 1hr at 33°C.  Snap frozen sections and cell suspensions were fixed for 15min in 478 
4% paraformaldehyde at room temperature.  Sections/cells were washed 3 x 5min in PBS and 479 
incubated with 125mM glycine (in PBS) for one minute at room temperature.  Sections/cells 480 
were washed 3 x 5 min in PBS, then permeabilized with 0.1% Triton-X100 for two minutes at 481 
4°C.  Sections/cells were washed 3 x 5 min in PBS, then blocked with 3% donkey serum in PBS 482 
for one hour at 37°C.  Sections/cells were incubated with primary antibody or 40μM JQ1-biotin 483 
(in 3% donkey serum in PBS) for one hour at 37°C and washed 3 x 5 min in PBS.  484 
Sections/cells were incubated with 5μg/mL (in 3% donkey serum in PBS) Alexafluor secondary 485 
antibody (Invitrogen) for 30min at 37°C, then washed 3 x 5min in PBS.  Sections/cells were 486 
then incubated with DAPI (Invitrogen, 5μg/mL in 3% donkey serum in PBS) and embedded in 487 
Prolong Gold Anti-fade reagent (Invitrogen).  Sections/cells were imaged with a Leica TCS SP8 488 
confocal microscope and pseudo-3D images were created using Velocity 6 software.  Minimal 489 
changes to immunofluorescence images (contrast and pseudo-coloring) were made using 490 
ImageJ.          491 
 492 
Chromatin immunoprecipitation and sequencing 493 
ChIP-seq for BRD4 and histone post-translational modifications was carried out as previously 494 
described with minor modifications (61).  Cells were cross-linked in 1% formaldehyde in PBS 495 
for 10 minutes at room temperature.  The reaction was quenched with 125mM glycine in PBS 496 
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for five minutes at room temperature.  After cell lysis, lysates were sonicated for 20 minutes 497 
with a Covaris S220 sonicator (5% duty cycle, 140 watts peak incident power, 200 cycles per 498 
burst).  For each IP, 500μg of protein (measured with BCA assay) from the cell lysate, 30μL 499 
protein G Dynabeads (Life Technologies), and 5μg-10μg of antibody or IgG (Pierce 31235) 500 
were used.  ChIP libraries for sequencing were prepared using 5ng DNA and the NEBNext 501 
Ultra DNA library prep kit for Illumina.  Size selection was performed using AMPure XP beads 502 
(Beckman Coulter, Inc. #A63881).  Libraries were sequenced using a NextSeq 500 machine 503 
(Illumina) as per manufacturer's protocols.   504 
 505 
ChIP-seq data analysis 506 
ChIP-seq data generated using a NextSeq 500 were demultiplexed using the bcl2fastq utility 507 
(02.14.01.07).  Data were then aligned using bowtie 0.12.7 (parameters -m 1 --best) to mouse 508 
genomic assembly mm9. 509 
UCSC Genome Browser Tracks 510 
Visual tracks of ChIP-seq data were generated in the following way.  For each sample, the 511 
aligned data file for PCR duplicated reads was filtered (i.e., any set of aligned reads with the 512 
same chromosome, start, and stop coordinates was reduced to a single representative). Coverage 513 
maps were then created using the BEDTools utility genomeCoverageBed. Resulting bedGraphs 514 
were scaled using the RPKM coefficient, a measure of the number of billions of bases 515 
sequenced per sample, to correct for sequencing efficiency biases. Finally, an input coverage 516 
map was subtracted for the BRD4 and each histone PTM coverage map. The BRDT data from 517 
(25) were treated similarly. 518 
Genome Compartment Plot 519 
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The genomic compartment table was generated by first calling peaks for each histone PTM or 520 
BRD4 using SICER (peaks were called against input as the background; window, fragment, and 521 
gap size parameters were fixed at 200bp; and the FDR was controlled at 0.1%). Previously 522 
published peak locations from (25) were used for BRDT. Peak locations were overlapped using 523 
BEDTools' intersect utility with RefSeq promoters, exons, and introns, in an exclusive way: if a 524 
peak overlapped a promoter, it was removed from consideration for overlap with exons or 525 
introns, and if it overlapped an exon it was removed from consideration for overlap with introns. 526 
Expression versus ChIP Enrichment Heatmap 527 
RefSeq transcripts were assessed for expression in round spermatids by loading two previously 528 
published replicate data sets (GSM95950 and GSM95951 in GEO series GSE4193) into the 529 
Partek Genomics Suite software package. Data were background-corrected with GC-RMA, 530 
quantile-normalized, and median polished along with all other data sets in the GSE4193 series. 531 
Promoters (1kb upstream regions) associated with these expression-scored transcripts were 532 
assessed for numbers of aligned tags in each indicated ChIP. Tag counts were then normalized 533 
to the number of millions of tags sequenced as well as input. Brightness for each track is scaled 534 
to the maximum ChIP value in that track; tracks are sorted in order of least expressed to most 535 
expressed genes in GSM95950. 536 
Expression Boxplots 537 
BRDT target genes are as described in (25). BRD4 target genes were those with a SICER-538 
determined BRD4 peak in the promoter where the peak enrichment was in the 90th percentile of 539 
all BRD4 peaks. For each of the three gene sets, expression enrichments were determined using 540 
GSM95950 (data processing described above) and ChIP-seq enrichments were determined using 541 
normalized tag counts at the promoter (data processing described above). Table 2 p-values and 542 
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W statistics (reflecting expression distribution and promoter acetylation distribution differences 543 
between genes bound by BRD4, BRDT, both, or neither) were estimated using the one-sided 544 
Mann-Whitney test in R. 545 
Gene Ontology Pie Charts 546 
Gene Ontology enrichment analysis of BRD4 target genes, BRDT target genes, and co-bound 547 
genes was done using DAVID (62). GO terms in the "Biological Process" hierarchy were 548 
collapsed to a single representative term if they shared the same gene; if one GO term's 549 
associated target genes were a subset of another's, that GO term was dropped in favor of the 550 
other. GO terms were further combined if they shared more than 15 transcripts. GO terms are 551 
represented by their overall gene "real estate." Each gene is given a vote inversely proportional 552 
to the number of terms it appears in. Each term's weight is the sum of the votes of its genes. 553 
Finally, pie charts were simplified by visual inspection. 554 
Promoter Heatmap 555 
Genes enriched in the Gene Ontology category "Spermatogenesis" (GO:0007283) were 556 
associated with RefSeq transcripts using UniProt and DAVID. For each transcript, a vector 557 
describing the ChIP-seq enrichment profile around the TSS (2.5kb upstream and 2.5kb 558 
downstream) was assessed for BRD4 and BRDT (ChIP-seq enrichment data were normalized to 559 
input, length, and number of millions of reads, as above). Profiles were sorted top-to-bottom by 560 
overall BRD4 enrichment intensity. The maximum green in each plot was determined by the 561 
enrichment value at the 90th percentile. 562 
 563 
Immunoprecipitation and mass spectrometry 564 
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Antibody-coupled beads were prepared by incubating 30μL/IP protein G Dynabeads (Life 565 
Technologies) with 10μg primary antibody or rabbit IgG (Pierce 31235) in 0.5% BSA-PBS for 566 
six hours at 4°C with rotation. Cells were resuspended in lysis buffer (20mM Tris  pH 7.5, 1mM 567 
MgCl2 , 1mM CaCl2, 137mM NaCl, 10% glycerol, 1% NP-40, Complete Protease inhibitor 568 
EDTA-free (Roche), 10mM NaB, 300nM Trichostatin A), after which 12.5 U/mL Benzonase 569 
was added.  Lysates were incubated for one hour at 4°C with rotation and then cleared by 570 
centrifugation at 14,000 rpm for 10 minutes.  Supernatant was removed and protein 571 
concentration was measured with Bradford dye.  After incubating with antibody, beads were 572 
washed three times with 1mL buffer.  One mg protein from the lysate was added to the beads 573 
and incubated overnight at 4°C with rotation.  Beads were washed five times with 1mL buffer.  574 
Beads were resuspended in 30μL sample buffer and incubated for five minutes at 90°C.  Eluate 575 
was separated from the beads, separated on a 4-12% 1mm Bis-Tris NuPAGE protein gel, and 576 
analyzed for enriched histone modifications compared to input samples with mass spectrometry 577 
(MS).   578 
In-gel histone proteins were derivatized twice with a mixture of propionic anhydride and 579 
100 mM ammonium bicarbonate (1:1) for 15 min under vigorous vortexing and then digested 580 
with 12.5 ng/μL of trypsin at room temperature overnight. Resultant histone peptides were 581 
extracted from the gel, re-propionylated twice, and then desalted using C18-based homemade 582 
stage-tips before MS analysis. Desalted peptides were separated by reverse phase nanospray 583 
liquid chromatography with the Thermo Scientific Easy-nLC 1000 system and an in-house 584 
packed C18 resin column (15cm in length and 3µm in particle size). Buffer A is water with 0.1% 585 
formic acid. Buffer B is acetonitrile with 0.1% formic acid. Histone peptides were eluted by a 586 
gradient from 2% to 30% of buffer B for 35 min, 30% to 98% of buffer B for 20 min followed 587 
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by a wash at 98% of buffer B for 15min with a flow rate of 200 nL/min.  Mass spectrometry was 588 
performed on a Thermo Scientific Orbitrap Velos Pro hybrid ion trap-Orbitrap mass 589 
spectrometer. Each cycle includes one full MS scan (m/z 290 to 1400, resolution of 60,000, 590 
AGC target value of 1x106), followed by seven data-dependent MS2 scans of the most intense 591 
peptide ions using CID (normalized collision energy of 35%, isolation width of 3 m/z, AGC 592 
target value of 1x104). In the section between 23 min and 45 min, MS2 scans targeting precursor 593 
ions with m/z of 528.30, 570.84, 768.95, 761.94 and 754.93 (isolation width of 1 m/z) were 594 
performed for the determination of acetylation sites on histone peptides with multiple lysines. 595 
Dynamic exclusion of 25 s was used to prevent repeated analysis of the same components. Ions 596 
with a charge state of one or more than four and a rejection list of common contaminant ions 597 
were excluded from the analysis. Histone peptides were identified based on retention times and 598 
tandem MS. Abundance of histone peptides were quantified by integrating the area under each 599 
peak in the MS chromatogram using Thermo Scientific Xcalibur Qual Browser. The LC-600 
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TABLES 821 
Table 1: ChIP-seq data alignment information  822 














Input 54990464 35623672 32940684 64.78 92.47 90.64 
H3 71828757 37798741 30151960 52.62 79.77 82.96 
H3K9me3 84339867 39799707 27591619 47.19 69.33 75.92 
H3K9ac 67856707 48595679 34042406 71.62 70.05 93.67 
H4K5ac 66596815 46239262 34065138 69.43 73.67 93.73 
H4K8ac 79795471 48838021 29541448 61.20 60.49 81.28 
H4K12ac 71252246 46341541 33485169 65.04 72.26 92.14 
H4K16ac 77287145 49326598 28973938 63.82 58.74 79.72 
H4ac 70049830 48662721 32799658 69.47 67.40 90.25 
BRD4 84730635 47671985 24864246 56.26 52.16 68.41 
 824 
Table 2: Calculation of significant differences for Figures 6B and C 825 
Figure 6B    
Comparison of BRD4-, BRDT-, or co-bound gene expression 
Test W Statistic p-value  
BRD4 vs. All Genes  W = 2683292 p < 2.2e-16  
BRDT vs. All Genes W = 1729944 p < 2.2e-16  
 38
Co-bound vs. All Genes W = 378363 p < 2.2e-16  
Co-bound vs. BRD4 W = 181821 p = 2.6e-08  
Co-bound vs. BRDT W = 127587 p = 6.8e-11  
    
Figure 6C    
Comparison of BRD4-, BRDT-, or co-bound gene promoter acetylation level 
Test Histone PTM W Statistic p-value 
BRD4 vs. BRDT H3K9ac W = 1403278 p < 2.2e-16 
BRD4 vs. BRDT H4K5ac W = 1484792 p < 2.2e-16 
BRD4 vs. BRDT H4K8ac W = 1466692 p < 2.2e-16 
BRD4 vs. BRDT H4K12ac W = 1468998 p < 2.2e-16 
BRD4 vs. BRDT H4K16ac W = 1444708 p < 2.2e-16 
BRD4 vs. BRDT H4Kac W = 1479768 p < 2.2e-16 
Co-bound vs. BRD4 H3K9ac W = 276948.5 p = 7.411e-16 
Co-bound vs. BRDT H3K9ac W = 158058 p < 2.2e-16 
Co-bound vs. BRD4 H4K5ac W = 273017.5 p = 2.435e-14 
Co-bound vs. BRDT H4K5ac W = 162835.5 p < 2.2e-16 
Co-bound vs. BRD4 H4K8ac W = 277942.5 p = 2.972e-16 
Co-bound vs. BRDT H4K8ac W = 162476.5 p < 2.2e-16 
Co-bound vs. BRD4 H4K12ac W = 272689 p = 3.232e-14 
Co-bound vs. BRDT H4K12ac W = 161513.5 p < 2.2e-16 
Co-bound vs. BRD4 H4K16ac W = 271330.5 p = 1.027e-13 
Co-bound vs. BRDT H4K16ac W = 158641.5 p < 2.2e-16 
Co-bound vs. BRD4 H4Kac W = 277562 p = 4.223e-16 
Co-bound vs. BRDT H4Kac W = 162543 p < 2.2e-16 
 826 
Table 3: Mass spectrometry analysis of BRD4-immunoprecipitated histones from round 827 
spermatids 828 
Quantification of the degree of acetylation or methylation of histone H3 (amino acids 9 to 17, 829 
KSTGGKAPR) or H4 peptide (amino acids 4 to 17, GKGGKGLGKGGAKR).  Shown are 830 
average ratios of the percentage of peptide of H3 or H4 in BRD4-immunoprecipitated chromatin 831 
to total chromatin.  Standard deviation is calculated for two and four biological replicates for H3 832 
and H4, respectively. 833 
Peptide AVG IP/Total St Dev (±) 
H3 9-17   
Unmodified 1.02 0.18 
 39
H3K9me1 0.65 0.28 
H3K9me2 1.26 0.73 
H3K9me3 4.24 1.51 
H3K9ac 1.11 1.58 
H3K14ac 1.09 0.08 
H3K9me1K14ac 0.09 0.13 
H3K9me2K14ac 1.35 1.09 
H3K9me3K14ac 3.04 2.97 
H3K9,14ac 0.00 0.00 
   
H4 4-17   
Unmodified 1.14 0.20 
H4Kac1 0.61 0.12 
H4Kac2 0.98 0.08 
H4Kac3 3.72 1.04 
H4Kac4 10.07 5.17 
   
Unmodified 1.17 0.21 
H4K5ac 3.31 2.85 
H4K8ac 2.67 4.89 
H4K12ac 0.48 0.51 
H4K16ac 0.87 0.42 
H4K5,8ac 2.54 0.96 
H4K5,12ac 1.36 0.87 
H4K5,16ac 0.99 0.33 
H4K8,12ac 0.83 0.35 
H4K8,16ac 0.85 0.24 
H4K12,16ac 0.80 0.13 
H4K5,8,12ac 3.73 2.69 
H4K5,8,16ac 4.18 1.51 
H4K5,12,16ac 3.30 2.68 
H4K8,12,16ac 2.82 1.54 
H4K5,8,12,16ac 10.93 6.10 
 834 
Table 4: Mass spectrometry analysis of BRD4-immunoprecipitated H4 during 835 
spermatogenesis 836 
Quantification of the degree of acetylation (% total peptide) of histone H4 peptide (amino acids 837 
4 to 17, GKGGKGLGKGGAKR) in total and BRD4-immunoprecipitated chromatin from 838 
 40
spermatocytes (Sc), round spermatids (RSp) and elongating/condensing spermatids (E/CSp).  839 
Standard deviation is calculated for two biological replicates.  840 
 Avg Total St Dev Total Avg BRD4 IP St Dev BRD4 IP 
Sc     
Unmodified 48.75% 0.89% 53.01% 18.06% 
1ac 39.41% 1.37% 27.42% 2.80% 
2ac 10.45% 2.52% 9.88% 8.31% 
3ac 0.94% 0.15% 3.60% 2.42% 
4ac 0.45% 0.10% 6.09% 4.52% 
RSp     
Unmodified 30.39% 0.46% 37.40% 4.57% 
1ac 57.27% 1.28% 40.78% 2.51% 
2ac 8.67% 1.13% 7.70% 0.49% 
3ac 2.26% 0.01% 4.27% 1.52% 
4ac 1.42% 0.32% 9.85% 3.08% 
E/CSp     
Unmodified 35.91% 0.72% 42.74% 7.08% 
1ac 34.90% 3.29% 35.69% 3.77% 
2ac 12.51% 0.63% 11.43% 1.50% 
3ac 8.55% 0.76% 5.78% 1.22% 
4ac 8.12% 1.18% 4.35% 0.59% 
 841 
 842 
FIGURE LEGENDS 843 
Figure 1: BRD4 is expressed in meiotic cells and spermatids, but not in mature sperm 844 
(A) Schematic of the progression of spermatogenesis beginning with meiotic cells 845 
(spermatocytes) and progressing through spermiogenesis from round to elongating to 846 
condensing spermatids.  Changes in cell (tan) and nucleus (blue) size and shape are 847 
shown for reference in figures to follow. 848 
(B) Western blot analysis of whole cell extracts from spermatocytes (Sc), round spermatids 849 
(RSp), elongating/condensing spermatids (E/CSp), a mixture of round, elongating, and 850 
condensing spermatids (R/E/CSp) obtained with STA-PUT velocity sedimentation, and 851 
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mature sperm (Sperm).  Asterisks mark the full length BRD4 isoform and the arrow 852 
indicates a novel shorter BRD4 peptide in spermatids.  Peptide competition of BRD4 853 
antibody shows specificity of the BRD4 antibody.   854 
 855 
Figure 2: BRD4 forms a ring around the nucleus of spermatids as histones become hyper-856 
acetylated 857 
(A)  Indirect immunofluorescence of cryosectioned mouse testes tissue shows that BRD4 858 
(green) forms a ring around the nucleus (DAPI-stained DNA shown in blue) of early 859 
(top panel) to late (bottom panel) elongating spermatids. The ring is absent in all non-860 
spermatid cell types such as spermatocytes (Sc).  861 
(B) Indirect immunofluorescence of cryosectioned mouse testes tissue shows that the BRD4 862 
ring (green) forms at the onset of histone H4 hyper-acetylation (red) in the nucleus 863 
(DAPI in blue) of early (top panel) to late (bottom panel) elongating spermatids.   864 
Stage of spermatogenesis shown in upper left hand corner of each panel.  Separation of 865 
spermatocytes (Sc) and spermatids (Sp) within the seminiferous tubule is indicated with a 866 
grey dotted line.  Inset shows 3x magnification of the spermatids outlined with a dotted 867 
square.     868 
(C) and (D) Indirect immunofluorescence of a mixed population of spermatogenic cells 869 
shows that BRD2 and BRDT (red) are diffusely localized in the nuclei (DAPI in blue) of 870 
spermatocytes (Sc) and round spermatids (RSp), but not condensing spermatids (CSp). 871 
Scale bar represents 10μm.    872 
 873 
Figure 3: BRD4 forms a ring within the nuclear envelope at the base of the acrosome 874 
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(A) Indirect immunofluorescence of BRD4 (green), Lamin B1 (red), and DAPI-stained DNA 875 
(blue) in a round spermatid.  Asterisk indicates location of the acrosome.   876 
(B) Indirect immunofluorescence of Lamin B1 (green), the acrosome (detected with PNA in 877 
red), and DAPI-stained DNA (blue) in a round spermatid.  878 
(C) Indirect immunofluorescence of BRD4 (green), acrosome (detected with PNA in red), and 879 
DAPI-stained DNA (blue) in a round spermatid (top), early elongating spermatid (middle), 880 
and condensing spermatid (bottom).  881 
(D) Indirect immunofluorescence of fluorophore-conjugated streptavidin (red) with (top) or 882 
without (bottom) JQ1-biotin and DAPI-stained DNA (blue) in a mixed population of 883 
spermatogenic cells.  884 
(E) Indirect immunofluorescence of BRD4 (green), JQ1-biotin (red), and DAPI-stained DNA 885 
(blue) in a late round (top panel) and elongating (bottom panel) spermatid.  886 
(F) Indirect immunofluorescence of the acrosome (detected with PNA in green), JQ1-biotin 887 
(red), and DAPI-stained DNA (blue) in a condensing spermatid.  888 
Scale bar represents 5μm (A-C,E,F) and 10μm (D). 889 
 890 
Figure 4: BRD4 does not form a ring in Hrb-/- acrosomal mutant mice 891 
(A) Indirect immunofluorescence of the acrosome (detected with PNA in green) and DNA 892 
(DAPI in blue) in testes tissue sections from wild-type and Hrb-/- mice.  The stage of 893 
spermatogenesis is shown in the upper left hand corner of each panel.  894 
(B) Indirect immunofluorescence of BRD4 (green) and DNA (DAPI in blue) in elongating 895 
spermatids of cryosectioned testes tissue from Hrb+/- (left) and Hrb-/- (right) mice.   896 
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Inset shows 3x magnification of the spermatids outlined with a dotted square.  Scale bar 897 
represents 10μm. 898 
 899 
Figure 5: BRD4 is enriched at the promoters of active genes in round spermatids 900 
(A) ChIP sequencing of BRD4 and various histone PTMs reveals that BRD4 and histone H3 901 
and H4 acetylation are associated with gene-rich regions of the genome while H3K9me3 is 902 
enriched in intergenic, gene poor regions.  UCSC-defined genes are shown at the bottom in 903 
dark blue.  Genomic location is indicated at the top.  The y axis is ChIP enrichment 904 
(normalized to input).  The x axis is DNA sequence. 905 
(B) Percentage of defined ChIP-seq peaks of BRD4, BRDT, and various histone PTMs in 906 
promoter (1kb upstream of the TSS), gene (intron versus exon), or intergenic regions in 907 
round spermatids. 908 
(C) ChIP sequencing of BRD4 and various histone PTMs at housekeeping (Actb) and 909 
spermatogenesis-specific (Tnp1) transcriptionally active genes and an inactive gene, Myc.  910 
BRD4 is not present at all gene promoters that are enriched for H3/H4 acetylation (Vps45).  911 
UCSC-defined genes are shown at the bottom in dark blue.  The y axis is ChIP enrichment 912 
(normalized to input).  The x axis is DNA sequence. 913 
 914 
Figure 6: BRD4 and BRDT bind to different subsets of transcriptionally active genes in 915 
round spermatids 916 
(A) Heat map representation of ChIP-sequencing enrichment at promoters of all genes (green) 917 
compared to the level of transcription of these genes (red) in round spermatids.  Brightness 918 
indicates higher levels of enrichment or transcription.  919 
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(B) Box and whisker plot of transcription levels of genes that are bound by BRD4, BRDT, or 920 
both.  Overall transcription levels are shown for spermatogenesis-specific genes (“Sperm.”) 921 
and all genes, as a reference. 922 
(C) Box and whisker plot of enrichment levels of different histone PTMs at the gene promoters 923 
(1kb upstream of the TSS) bound by BRD4, BRDT, or both (presence or absence of 924 
binding indicated with “+” or “–“, respectively, at bottom).   925 
(D) Pie chart representations of GO Terms of genes enriched for BRD4 (left), BRDT (middle), 926 
or both (right) in round spermatids. 927 
(E) ChIP sequencing of BRD4, BRDT, and various histone PTMs at promoters of genes 928 
present in the top-most represented GO Term category from the corresponding pie chart in 929 
(D) above.  UCSC-defined genes are shown at the bottom in blue.  The y axis is ChIP 930 
enrichment (normalized to input).  The x axis is DNA sequence.  931 
(F) Heat map representation of BRD4 and BRDT enrichment around the TSS (± 2.5kb) of 932 
spermatogenesis-specific genes in round spermatids.  Brightness indicates higher levels of 933 
enrichment. 934 
 935 
Figure 7: BRD4 association with poly-acetylated histone H4 diminishes in late spermatids 936 
as acetylated histones are removed from the condensing nucleus 937 
(A) Mass spectrometry analysis of BRD4-immunoprecipitated histones from round spermatids.  938 
Heatmap representation of enrichment of acetylation or methylation of histone H3 (amino 939 
acids 9 to 17, KSTGGKAPR) or H4 peptide (amino acids 4 to 17, 940 
GKGGKGLGKGGAKR) in BRD4-immunoprecipitated chromatin normalized to total 941 
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chromatin (log transformed).  Raw values used to generate the heatmaps are found in Table 942 
3. 943 
(B) Comparison of degree of H4 peptide acetylation (amino acids 4 to 17, 944 
GKGGKGLGKGGAKR) in total and BRD4-immunoprecipitated (IP) chromatin over the 945 
course of spermatogenesis.  Black and grey bars indicate changes in H4 acetylation from 946 
spermatocytes (Sc) to round spermatids (RSp) and from round spermatids to 947 
elongating/condensing spermatids (ECSp), respectively, via log-transformed ratio of 948 
percentage acetylated H4 peptide.  Raw values used to generate the graphs are found in 949 
Table 4. 950 
(C) Indirect immunofluorescence of BRD4 (green), H4K5,8,12,16ac (red), and DAPI-stained 951 
DNA (blue) in a condensing spermatid.  Scale bar represents 5μm.    952 
(D) Model showing the locations of different cellular features associated with the spermatid 953 
nucleus.  BRD4 (green) forms a ring structure between the nucleus (blue) and the 954 
acroplaxome (red) in a key region of the nuclear membrane where the Lamin B1- and 955 
nuclear pore-enriched posterior portion meets the acrosome-associated, nuclear pore-956 
depleted anterior portion.   957 











